ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 122 filers reported holding ANAPTYSBIO INC in Q3 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $282,000 | +24.8% | 8,085 | -3.0% | 0.00% | 0.0% |
| Q3 2021 | $226,000 | -12.1% | 8,331 | -16.0% | 0.00% | 0.0% |
| Q2 2021 | $257,000 | +25.4% | 9,919 | +4.3% | 0.00% | 0.0% |
| Q1 2021 | $205,000 | -42.1% | 9,507 | -6.1% | 0.00% | -50.0% |
| Q3 2019 | $354,000 | -38.0% | 10,120 | -0.0% | 0.00% | -33.3% |
| Q2 2019 | $571,000 | -31.8% | 10,124 | -11.7% | 0.00% | -40.0% |
| Q1 2019 | $837,000 | +16.2% | 11,462 | +1.5% | 0.01% | 0.0% |
| Q4 2018 | $720,000 | -40.5% | 11,293 | -6.9% | 0.01% | -37.5% |
| Q3 2018 | $1,210,000 | +38.3% | 12,125 | -1.6% | 0.01% | +33.3% |
| Q2 2018 | $875,000 | -36.0% | 12,318 | -6.3% | 0.01% | -33.3% |
| Q1 2018 | $1,368,000 | -11.3% | 13,145 | -14.1% | 0.01% | -18.2% |
| Q4 2017 | $1,542,000 | – | 15,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |